{"title":"解锁微rna在糖尿病中的诊断和治疗潜力:文献计量学和可视化分析(2003-2023)。","authors":"Jiajing Yu, Kai Xia, Jiaming Feng, Zehui Xu, Zhuoyue Zhang, Guanyi Xiao, Huici Zhu, Wenlong Xue, Fengxi Chen, Xiaotong Xie","doi":"10.2147/JMDH.S533519","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>MicroRNAs (miRNAs) hold considerable therapeutic potential for diabetes mellitus (DM). Over the past few decades, substantial progress has been made in miRNA-related diabetes research; however, comprehensive bibliometric analyses in this field remain limited. This study aims to comprehensively review the research status of miRNAs in DM, including the contributions of countries, institutions, authors and published journals, and explore the latest progress, research hotspots, and future trends.</p><p><strong>Methods: </strong>Bibliometric analysis was conducted using CiteSpace and VOSviewer by searching relevant literature in the Web of Science Core Collection (WOSCC). With 5197 relevant publications retrieved from January 1, 2003, to October 31, 2023, the field of miRNAs in DM witnessed a generally upward trend in global publications.</p><p><strong>Results: </strong>Global publications on miRNAs in DM showed a sustained upward trajectory. China led in publication output and influence, likely linked to its high DM prevalence. Cluster analysis identified diabetic retinopathy and diabetic nephropathy as primary research foci among co-cited studies. Keyword analysis emphasizes the top 10 words like miRNA, expression, biomarker, insulin resistance, diabetes, diabetes nephropathy, apoptosis, cell, and oxidative stress.</p><p><strong>Conclusion: </strong>Research on miRNAs in DM has grown significantly, with emphasis on understanding pathogenesis and identifying therapeutic targets. This field will be further studied and translated into clinical practice in the future.</p>","PeriodicalId":16357,"journal":{"name":"Journal of Multidisciplinary Healthcare","volume":"18 ","pages":"5227-5247"},"PeriodicalIF":2.4000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399103/pdf/","citationCount":"0","resultStr":"{\"title\":\"Unlocking the Diagnostic and Therapeutic Potential of microRNA in Diabetes: A Bibliometric and Visualized Analysis (2003-2023).\",\"authors\":\"Jiajing Yu, Kai Xia, Jiaming Feng, Zehui Xu, Zhuoyue Zhang, Guanyi Xiao, Huici Zhu, Wenlong Xue, Fengxi Chen, Xiaotong Xie\",\"doi\":\"10.2147/JMDH.S533519\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>MicroRNAs (miRNAs) hold considerable therapeutic potential for diabetes mellitus (DM). Over the past few decades, substantial progress has been made in miRNA-related diabetes research; however, comprehensive bibliometric analyses in this field remain limited. This study aims to comprehensively review the research status of miRNAs in DM, including the contributions of countries, institutions, authors and published journals, and explore the latest progress, research hotspots, and future trends.</p><p><strong>Methods: </strong>Bibliometric analysis was conducted using CiteSpace and VOSviewer by searching relevant literature in the Web of Science Core Collection (WOSCC). With 5197 relevant publications retrieved from January 1, 2003, to October 31, 2023, the field of miRNAs in DM witnessed a generally upward trend in global publications.</p><p><strong>Results: </strong>Global publications on miRNAs in DM showed a sustained upward trajectory. China led in publication output and influence, likely linked to its high DM prevalence. Cluster analysis identified diabetic retinopathy and diabetic nephropathy as primary research foci among co-cited studies. Keyword analysis emphasizes the top 10 words like miRNA, expression, biomarker, insulin resistance, diabetes, diabetes nephropathy, apoptosis, cell, and oxidative stress.</p><p><strong>Conclusion: </strong>Research on miRNAs in DM has grown significantly, with emphasis on understanding pathogenesis and identifying therapeutic targets. This field will be further studied and translated into clinical practice in the future.</p>\",\"PeriodicalId\":16357,\"journal\":{\"name\":\"Journal of Multidisciplinary Healthcare\",\"volume\":\"18 \",\"pages\":\"5227-5247\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-08-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399103/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Multidisciplinary Healthcare\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/JMDH.S533519\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Multidisciplinary Healthcare","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JMDH.S533519","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
背景:MicroRNAs (miRNAs)在糖尿病(DM)中具有相当大的治疗潜力。在过去的几十年里,mirna相关的糖尿病研究取得了实质性进展;然而,在这一领域的综合文献计量分析仍然有限。本研究旨在全面综述DM中mirna的研究现状,包括国家、机构、作者和发表期刊的贡献,并探讨最新进展、研究热点和未来趋势。方法:利用CiteSpace和VOSviewer检索Web of Science Core Collection (WOSCC)的相关文献,进行文献计量学分析。从2003年1月1日到2023年10月31日,共检索到5197篇相关文献,DM中miRNAs领域在全球出版物中总体呈上升趋势。结果:全球关于DM中mirna的出版物呈现持续上升的趋势。中国在出版物产量和影响力方面处于领先地位,这可能与其糖尿病的高患病率有关。聚类分析发现糖尿病视网膜病变和糖尿病肾病是共被引研究的主要研究焦点。关键词分析强调miRNA、表达、生物标志物、胰岛素抵抗、糖尿病、糖尿病肾病、凋亡、细胞、氧化应激等前10个关键词。结论:mirna在糖尿病中的研究已显著增加,重点是了解发病机制和确定治疗靶点。这一领域将在未来进一步研究并转化为临床实践。
Unlocking the Diagnostic and Therapeutic Potential of microRNA in Diabetes: A Bibliometric and Visualized Analysis (2003-2023).
Background: MicroRNAs (miRNAs) hold considerable therapeutic potential for diabetes mellitus (DM). Over the past few decades, substantial progress has been made in miRNA-related diabetes research; however, comprehensive bibliometric analyses in this field remain limited. This study aims to comprehensively review the research status of miRNAs in DM, including the contributions of countries, institutions, authors and published journals, and explore the latest progress, research hotspots, and future trends.
Methods: Bibliometric analysis was conducted using CiteSpace and VOSviewer by searching relevant literature in the Web of Science Core Collection (WOSCC). With 5197 relevant publications retrieved from January 1, 2003, to October 31, 2023, the field of miRNAs in DM witnessed a generally upward trend in global publications.
Results: Global publications on miRNAs in DM showed a sustained upward trajectory. China led in publication output and influence, likely linked to its high DM prevalence. Cluster analysis identified diabetic retinopathy and diabetic nephropathy as primary research foci among co-cited studies. Keyword analysis emphasizes the top 10 words like miRNA, expression, biomarker, insulin resistance, diabetes, diabetes nephropathy, apoptosis, cell, and oxidative stress.
Conclusion: Research on miRNAs in DM has grown significantly, with emphasis on understanding pathogenesis and identifying therapeutic targets. This field will be further studied and translated into clinical practice in the future.
期刊介绍:
The Journal of Multidisciplinary Healthcare (JMDH) aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines. This includes studies and reviews conducted by multidisciplinary teams as well as research which evaluates or reports the results or conduct of such teams or healthcare processes in general. The journal covers a very wide range of areas and we welcome submissions from practitioners at all levels and from all over the world. Good healthcare is not bounded by person, place or time and the journal aims to reflect this. The JMDH is published as an open-access journal to allow this wide range of practical, patient relevant research to be immediately available to practitioners who can access and use it immediately upon publication.